News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phase Bioscience, Inc. Licenses Key Patent Portfolio, Adds Expert in Protein Engineering IP Protection


9/23/2008 8:24:10 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--Phase Bioscience, Inc., (PhaseBioTM) a development stage biotechnology company, announced today that it has secured worldwide, exclusive rights to several issued patents relevant to key aspects in the therapeutic use of elastin-like polypeptide (ELP) technology. Collectively, these patents are known as the “Urry Portfolio.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES